Omnicell (OMCL) Tops Q3 EPS by 5c; Lowers Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Benchmark Downgrades Omnicell (OMCL) to Hold
November 3, 2022 6:11 AM EDTBenchmark analyst Bill Sutherland downgraded Omnicell (NASDAQ: OMCL) from Buy to Hold.
The analyst comments "Yesterday, OMCL shocked investors with downwardly revised 2022 expectations that included a 29% drop in 2022 product bookings and implied 4Q22 revenue and non-GAAP EBITDA declines of 7% and 76%, respectively. Nearly the entire problem relates to the XT automated dispensing cabinets (ADCs), which represent over half of total product bookings and, unlike the rest... More
